402 related articles for article (PubMed ID: 20164322)
1. Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis.
Baracos VE; Reiman T; Mourtzakis M; Gioulbasanis I; Antoun S
Am J Clin Nutr; 2010 Apr; 91(4):1133S-1137S. PubMed ID: 20164322
[TBL] [Abstract][Full Text] [Related]
2. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index.
Martin L; Birdsell L; Macdonald N; Reiman T; Clandinin MT; McCargar LJ; Murphy R; Ghosh S; Sawyer MB; Baracos VE
J Clin Oncol; 2013 Apr; 31(12):1539-47. PubMed ID: 23530101
[TBL] [Abstract][Full Text] [Related]
3. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
4. Associations between severe co-morbidity and muscle measures in advanced non-small cell lung cancer patients.
Grønberg BH; Valan CD; Halvorsen T; Sjøblom B; Jordhøy MS
J Cachexia Sarcopenia Muscle; 2019 Dec; 10(6):1347-1355. PubMed ID: 31385663
[TBL] [Abstract][Full Text] [Related]
5. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
6. A window beneath the skin: how computed tomography assessment of body composition can assist in the identification of hidden wasting conditions in oncology that profoundly impact outcomes.
Daly LE; Prado CM; Ryan AM
Proc Nutr Soc; 2018 May; 77(2):135-151. PubMed ID: 29745361
[TBL] [Abstract][Full Text] [Related]
7. Central tenet of cancer cachexia therapy: do patients with advanced cancer have exploitable anabolic potential?
Prado CM; Sawyer MB; Ghosh S; Lieffers JR; Esfandiari N; Antoun S; Baracos VE
Am J Clin Nutr; 2013 Oct; 98(4):1012-9. PubMed ID: 23966429
[TBL] [Abstract][Full Text] [Related]
8. Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lung.
Kazemi-Bajestani SMR; Becher H; Butts C; Basappa NS; Smylie M; Joy AA; Sangha R; Gallivan A; Kavsak P; Chu Q; Baracos VE
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1070-1082. PubMed ID: 31293070
[TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
10. What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated?
Crown AL; Cottle K; Lightman SL; Falk S; Mohamed-Ali V; Armstrong L; Millar AB; Holly JM
Clin Endocrinol (Oxf); 2002 Jun; 56(6):723-33. PubMed ID: 12072041
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenic obesity by the ESPEN/EASO criteria for predicting mortality in advanced non-small cell lung cancer.
Zhou J; Luo L; Xie L; Hu S; Tan L; Lei X; Luo X; Yang M
Clin Nutr; 2023 Jun; 42(6):817-824. PubMed ID: 37084468
[TBL] [Abstract][Full Text] [Related]
13. Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study.
da Rocha IMG; Marcadenti A; de Medeiros GOC; Bezerra RA; Rego JFM; Gonzalez MC; Fayh APT
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):445-454. PubMed ID: 30924270
[TBL] [Abstract][Full Text] [Related]
14. Consequences of Late-Stage Non-Small-Cell Lung Cancer Cachexia on Muscle Metabolic Processes.
Murton AJ; Maddocks M; Stephens FB; Marimuthu K; England R; Wilcock A
Clin Lung Cancer; 2017 Jan; 18(1):e1-e11. PubMed ID: 27461772
[TBL] [Abstract][Full Text] [Related]
15. Factors which modulate the rates of skeletal muscle mass loss in non-small cell lung cancer patients: a pilot study.
Atlan P; Bayar MA; Lanoy E; Besse B; Planchard D; Ramon J; Raynard B; Antoun S
Support Care Cancer; 2017 Nov; 25(11):3365-3373. PubMed ID: 28593463
[TBL] [Abstract][Full Text] [Related]
16. A viscerally driven cachexia syndrome in patients with advanced colorectal cancer: contributions of organ and tumor mass to whole-body energy demands.
Lieffers JR; Mourtzakis M; Hall KD; McCargar LJ; Prado CM; Baracos VE
Am J Clin Nutr; 2009 Apr; 89(4):1173-9. PubMed ID: 19244378
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive proteome analysis of human skeletal muscle in cachexia and sarcopenia: a pilot study.
Ebhardt HA; Degen S; Tadini V; Schilb A; Johns N; Greig CA; Fearon KCH; Aebersold R; Jacobi C
J Cachexia Sarcopenia Muscle; 2017 Aug; 8(4):567-582. PubMed ID: 28296247
[TBL] [Abstract][Full Text] [Related]
18. Coix seed oil ameliorates cancer cachexia by counteracting muscle loss and fat lipolysis.
Liu H; Li L; Zou J; Zhou T; Wang B; Sun H; Yu S
BMC Complement Altern Med; 2019 Oct; 19(1):267. PubMed ID: 31615487
[TBL] [Abstract][Full Text] [Related]
19. Exploring the dietary protein intake and skeletal muscle during first-line anti-neoplastic treatment in patients with non-small cell lung cancer.
Tobberup R; Rasmussen HH; Holst M; Jensen NA; Falkmer UG; Bøgsted M; Delekta AM; Carus A
Clin Nutr ESPEN; 2019 Dec; 34():94-100. PubMed ID: 31677719
[TBL] [Abstract][Full Text] [Related]
20. Muscle derangement and alteration of the nutritional machinery in NSCLC.
Trestini I; Gkountakos A; Carbognin L; Avancini A; Lanza M; Molfino A; Friso S; Corbo V; Tortora G; Scarpa A; Milella M; Bria E; Pilotto S
Crit Rev Oncol Hematol; 2019 Sep; 141():43-53. PubMed ID: 31228648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
